Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

The frequency of missed breast cancers in women participating in a high-risk MRI screening program

Open access
Vreemann, S., Gubern-Merida, A., Lardenoije, S., Bult, P., Karssemeijer, N., Pinker, K., Mann, R. M. · 2018 · Breast Cancer Research and Treatment

Abstract

PURPOSE: To evaluate the frequency of missed cancers on breast MRI in women participating in a high-risk screening program. METHODS: Patient files from women who participated in an increased risk mammography and MRI screening program (2003-2014) were coupled to the Dutch National Cancer Registry. For each cancer detected, we determined whether an MRI scan was available (0-24 months before cancer detection), which was reported to be negative. These negative MRI scans were in consensus re-evaluated by two dedicated breast radiologists, with knowledge of the cancer location. Cancers were scored as invisible, minimal sign, or visible. Additionally, BI-RADS scores, background parenchymal enhancement, and image quality (IQ; perfect, sufficient, bad) were determined. Results were stratified by detection mode (mammography, MRI, interval cancers, or cancers in prophylactic mastectomies) and patient characteristics (presence of BRCA mutation, age, menopausal state). RESULTS: Negative prior MRI scans were available for 131 breast cancers. Overall 31% of cancers were visible at the initially negative MRI scan and 34% of cancers showed a minimal sign. The presence of a BRCA mutation strongly reduced the likelihood of visible findings in the last negative MRI (19 vs. 46%, P < 0.001). Less than perfect IQ increased the likelihood of visible findings and minimal signs in the negative MRI (P = 0.021). CONCLUSION: This study shows that almost one-third of cancers detected in a high-risk screening program are already visible at the last negative MRI scan, and even more in women without BRCA mutations. Regular auditing and double reading for breast MRI screening is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10549-018-4688-z

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 First the subtraction images of a breast cancer invasive ductal carcinoma (IDC) grade 3 (a), which were rated as invisible in the prior MRI (b), second row are the images (c) rated as minimal sign in the prior image (d) also showing an IDC grade 3, and the last row are the images of the current MRI (e) and the visible lesion in the prior MRI (f) an invasive lobular carcinoma grade 2
Fig. 1 First the subtraction images of a breast cancer invasive ductal carcinoma (IDC) grade 3 (a), which were rated as invisible in the prior MRI (b), second row are the images (c) rated as minimal sign in the prior image (d) also showing an IDC grade 3, and the last row are the images of the current MRI (e) and the visible lesion in the prior MRI (f) an invasive lobular carcinoma grade 2CC BY · PubMed Central
Fig. 2 An example of an interval cancer detected on ultrasound 9 months after prior MRI. This visible lesions was scored as BI-RADS 5 in re-evaluation; a subtraction image of an invasive ductal carcinoma grade 2 (pT1cN1mi (sn)) in transversal plane and b in coronal plane
Fig. 2 An example of an interval cancer detected on ultrasound 9 months after prior MRI. This visible lesions was scored as BI-RADS 5 in re-evaluation; a subtraction image of an invasive ductal carcinoma grade 2 (pT1cN1mi (sn)) in transversal plane and b in coronal planeCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. American College of Radiology (2013) ACR BI-RADS Atlas, 2013. Reston, American College of Radiology

Cited by

See all 37

Metadata

Authors
Vreemann, S., Gubern-Merida, A., Lardenoije, S., Bult, P., Karssemeijer, N., Pinker, K., & Mann, R. M.
Affiliations
  • Radboud University Medical Center (NL)
  • Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Vreemann, S.
Venue
Breast Cancer Research and Treatment
Published
2018-01-31
Volume
169
Issue
2
Pages
323-331
ISSN
  • 0167-6806 (ISSN-L)
  • 1573-7217
OpenAlex
W2785568893
Cited by
37
References
30
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 7 · 2019: 7 · 2018: 3
FWCI
3.28
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Breast Cancer Research and Treatment (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders
  • Seventh Framework Programme (601040)
  • The Netherlands Organisation for Health Research and Development (90514524)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Digital Radiography and Breast Imaging
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Keywords
breast MRI, BRCA mutations, image quality, background parenchymal enhancement, BI-RADS, interval breast cancer, prophylactic mastectomy, double reading
MeSH terms
Adult, Aged, Breast, Breast Neoplasms, Female, Humans, Magnetic Resonance Imaging, Mammography, Mass Screening, Middle Aged, BRCA1 Protein, BRCA2 Protein, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The frequency of missed breast cancers in women participating in a high-risk MRI screening program. https://app.cochat.ai/papers/10.1007/s10549-018-4688-z
The paper
Vreemann, S., Gubern-Merida, A., Lardenoije, S., Bult, P., Karssemeijer, N., Pinker, K., & Mann, R. M. (2018). The frequency of missed breast cancers in women participating in a high-risk MRI screening program. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-018-4688-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.